MTSL yields 59.35% · JNJ yields 2.13%● Live data
📍 MTSL pulled ahead of the other in Year 1
Combined, MTSL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MTSL + JNJ for your $10,000?
MER Telemanagement Solutions Ltd. engages in the provision of expense management and billing solutions and services. The firm is provider of solutions for online video advertising and telecommunications expense management (TEM) used by enterprises, and billing solutions used by information and telecommunication service providers. The firm operates through three segments: Enterprise, Service Providers and Video Advertising. Its Enterprise segment includes TEM solutions and services. Its Service Providers segment includes billing, mobile virtual network operator (MVNO) and machine-to-machine/Internet of Things (IoT/M2M) services and solutions. The online video advertising is provided through Vexigo Ltd. (Vexigo), a subsidiary of the Company, which has an in-house technology solution designed for content publishers. The Vexigo solution for online and mobile platforms supports multiple advertisement formats and interactive advertisement units.
Full MTSL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.